Collegium Pharmaceutical, Inc. COLL Return on invested capital

Return on invested capital at other companies

Pacira BioSciences, Inc.PCRX

2.7%—

BioventusBVS

12.2%+8.7pp

OrganonOGN

13.9%-2.2pp

Cumberland PharmaceuticalsCPIX

-54.6%+82.3pp

Supernus PharmaceuticalsSUPN

-6.4%-11.8pp

Acadia PharmaceuticalsACAD

10.7%-27.8pp

FAQ

What is Collegium Pharmaceutical, Inc.'s return on invested capital?

Collegium Pharmaceutical, Inc. (COLL) reported return on invested capital of 72.8% in Q2 2026.

How has Collegium Pharmaceutical, Inc.'s return on invested capital changed year-over-year?

Collegium Pharmaceutical, Inc.'s return on invested capital decreased by 38.3% year-over-year, from 118% to 72.8%.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s return on invested capital?

Over 2 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s return on invested capital has grown at a 29.0% compound annual growth rate (CAGR), from 75.5% to 125.6%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.